IKT · Inhibikase Therapeutics, Inc. · Debt
Market Cap
$337.68M
Shares
139.54M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1750149
CUSIP
45719W205
13F (30d)
75 filings
75 filers
Visit website
Investor relations